Latest News

Why One Investor Is Betting $30 Million on Western Union Despite 16% Stock Slide

Wall Street completely whiffed on PubMatic's earnings forecast, but smart investors should look beyond today's fireworks.

Cathie Wood remains very bullish on the cryptocurrency industry.

October CPI came in below expectations, while annual inflation has returned to its downward trajectory with a small decline.

Netflix will open its first major in-person amusement attraction called Netflix House in a Philadelphia suburb on Wednesday.

CoreWeave's depreciation schedule is similar to the big hyperscalers.

Investment Manager Adjusts Portfolio, Sells Construction Stock, According to Recent Filing

The U.S. faces an unprecedented surge in electricity demand, primarily fueled by the rapid expansion of artificial intelligence data centers, manufacturing reshoring, and the broad electrification of society.

Russian wheat prices are on the slide, with the average price for 12.5% protein wheat in the European part of the country falling by 150 rubles to 13,700 rubles per metric ton last week, according to SovEcon’s price monitoring.

Dogecoin (CRYPTO: DOGE) fell close to 3% on Tuesday, as large holders shifted roughly $32 million worth of DOGE to exchanges, putting sellers back in control.

Shares of visual content marketplace Getty Images (NYSE:GETY) fell in the afternoon session after the company reported mixed third-quarter 2025 results. The visual content marketplace reported revenue of $240 million, which was flat year-over-year but in line with Wall Street's estimates. The main highlight for investors was the company's profitability. Getty reported adjusted earnings per share of $0.08, which was 84.5% higher than the consensus analyst estimate of $0.04. The company also beat expectations for adjusted EBITDA, a key measure of profitability, coming in at $78.71 million. Adding to the positive sentiment, Getty Images' full-year EBITDA guidance of $292 million at the midpoint was also above analysts' projections.

Shares of fast-food company Yum China (NYSE:YUMC) jumped 2.6% in the afternoon session after the stock's positive momentum continued as the company reported solid third-quarter financial results that showed growth in key areas. The restaurant operator in China disclosed a year-over-year revenue increase between 3.5% and 4.4%, reaching $3.21 billion. Operating profit also saw a healthy jump of about 8% to $400 million, a sign of efficient business management. This performance was supported by a 1% growth in same-store sales, driven by value-focused pricing at its KFC and Pizza Hut locations. Furthermore, the company showed strong expansion by adding 536 new stores, bringing its total to approximately 17,500. While net income experienced a slight decline to $282 million from the previous year's $297 million, investors reacted positively to the overall robust growth in revenue and operations.

Shares of plant-based protein company Beyond Meat (NASDAQ:BYND) fell 7.5% in the afternoon session after the company reported a wider third-quarter loss and provided a weak sales forecast for the upcoming quarter, signaling ongoing demand issues. 

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 0.6% in the afternoon session after Canaccord Genuity Group raised its price target on the stock. The analyst firm lifted its target to $19.00 from $16.00 and kept a "buy" rating on the shares. 

Shares of electric vehicle charging company EVgo (NASDAQ:EVGO) fell 4.2% in the afternoon session after the stock's negative momentum continued as the company reported mixed third-quarter financial results that showed strong revenue growth but also a failure to meet sales expectations and a slightly wider-than-projected loss. 

Shares of payment processing company EVERTEC (NYSE:EVTC) jumped 6.2% in the afternoon session after the stock's positive momentum continued as the company reported earnings results that topped analyst estimates. The business services provider posted earnings of $0.92 per share for the quarter, which was $0.03 better than the consensus forecast of $0.89. This positive surprise appeared to capture investor attention. The move higher came even as some analysts adjusted their outlooks. For instance, Keefe, Bruyette & Woods kept its "Outperform" rating but cut its price target on the stock to $40 from $44. Similarly, Deutsche Bank also lowered its price target to $30 from $35 while keeping a "Hold" rating.

Shares of used automotive vehicle retailer Carmax (NYSE:KMX) jumped 2.8% in the afternoon session as the stock attempted a slight recovery after a major sell-off prompted by the sudden termination of its CEO and a dire preliminary financial report. The steep drop in the stock's price followed the company's announcement that CEO Bill Nash had been fired. CarMax also issued a disappointing preliminary outlook for its third quarter, forecasting a decrease in comparable store sales of 8% to 12%. In addition, the company projected earnings per share in a range of only $0.18 to $0.36, which was significantly below analysts' expectations of $0.69. Compounding the company's troubles, Morgan Stanley downgraded the stock from "Overweight" to "Equal-weight" and slashed its price target, pointing to execution problems and uncertainty around new leadership.

Shares of pharmaceutical company Organon (NYSE:OGN) fell 2.9% in the afternoon session after the company lowered its full-year sales guidance and analysts subsequently cut their price targets on the stock. This outlook overshadowed a third-quarter report where both earnings and revenue topped estimates. Following the earnings release, Organon provided a sales forecast that fell below analysts' expectations, prompting a reassessment of the company's value. JPMorgan reduced its price target to $12 from $14, citing headwinds for the company's Nexplanon and respiratory products. In a similar move, Morgan Stanley lowered its price target to $9 from $10, while maintaining its "Equal-Weight" rating on the shares.

Shares of vacation ownership company Marriott Vacations (NYSE:VAC) fell 7.3% in the afternoon session after an analyst at Mizuho downgraded the company's stock. The rating was moved from "Outperform" to "Neutral," and the price target was significantly cut by over 31% from $85.00 to $58.00. This analyst action appeared to reverse the positive sentiment from the previous day, when the stock jumped after the company announced the immediate departure of its CEO, John Geller. Matthew E. Avril was appointed as the interim chief executive. The downgrade from Mizuho followed other recent price target reductions from firms including Citizens and Barclays, signaling growing concerns among analysts about the company's outlook.

Shares of fuel cell technology Plug Power (NASDAQ:PLUG) fell 5.1% in the afternoon session after investors looked past its in-line third-quarter revenue and earnings beat to focus on the company's underlying profitability challenges. For the quarter, Plug Power reported revenue of $177.1 million, which was in line with analyst expectations, and an adjusted loss per share of $0.12, which was narrower than the anticipated $0.13 loss. However, the positive headline figures were overshadowed by deepening operational losses. The company's operating margin worsened significantly, indicating that expenses outpaced sales growth. Furthermore, Plug Power's gross margin remained deeply negative, and while its cash burn improved year-over-year, it still used $127.3 million in cash during the quarter, highlighting ongoing concerns about its path to sustainable profitability.

Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) fell 3.1% in the afternoon session after Japanese tech investment giant SoftBank announced it had sold its entire stake in the artificial intelligence company. In an earnings statement, SoftBank confirmed it had offloaded its shares for $5.83 billion. While the company stated the sale was part of a push for "asset monetization," the move was seen by some as a sign that SoftBank believed the best of Nvidia's stock gains were in the past. Because Nvidia is one of the largest companies on Wall Street, the sale was a heavy weight on the market. The news also added to broader concerns about high valuations in the technology sector, particularly around artificial intelligence stocks that had seen exceptional performance.

Shares of entertainment venue operator Lucky Strike (NYSE:LUCK) jumped 2.8% in the afternoon session after the stock's positive momentum continued as the company reported third-quarter financial results that surpassed analyst expectations. The entertainment company announced revenue of $292.3 million and earnings per share of -$0.12, both of which were better than what Wall Street had predicted. Adjusted EBITDA, a measure of profitability, also came in ahead of estimates at $72.65 million. Adding to the positive news, Lucky Strike confirmed its revenue guidance for the full year would remain at the midpoint of $1.29 billion, signaling stability. The strong quarter followed a recent show of confidence from within the company, as a director purchased 1,600 shares just days before the earnings release.

Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2.8% in the afternoon session after an analyst at Stephens & Co. raised the price target on the stock while maintaining a positive rating. Analyst Mason Carrico boosted the price target for Pacific Biosciences to $2.00 from $1.80, which marked an increase of over 11%. The firm also kept its 'Overweight' rating on the shares. This action signaled continued confidence from the analyst that the stock could perform well relative to others in its sector. The update provided a positive signal for investors, suggesting a more optimistic outlook on the company's valuation.

Shares of healthcare apparel company Figs (NYSE:FIGS) jumped 6.2% in the afternoon session after Barclays raised its price target for the company, and other analysts made similar positive adjustments. The bank lifted its price view to $9.00 from $7.00, though it kept its Equal-Weight rating on the shares. This move followed other firms that also grew more optimistic about the stock's potential. For instance, BTIG increased its price target to $10.00 from $9.00, and Telsey Advisory Group raised its target to $9.00. Adding to the positive backdrop, a report on the broader medical clothing market projected substantial growth, with the market expected to expand from $98.6 billion in 2024 to $173.2 billion by 2034.